Literature DB >> 4198684

Antimicrobial activity of tobramycin and gentamicin used in combination with cephalothin and carbenicillin.

J Klastersky, A Henri, L Vandenborre.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4198684     DOI: 10.1097/00000441-197307000-00002

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


× No keyword cloud information.
  15 in total

Review 1.  Principles of combination therapy.

Authors:  S Levin; A A Harris
Journal:  Bull N Y Acad Med       Date:  1975-10

2.  Interactions of ceftazidime and tobramycin in patients with normal and impaired renal function.

Authors:  G R Aronoff; R A Brier; R S Sloan; M E Brier
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

3.  Synergy between cephalosporin and aminoglycoside antibiotics against Providencia and Proteus.

Authors:  P J Hyams; M S Simberkoff; J J Rahal
Journal:  Antimicrob Agents Chemother       Date:  1974-06       Impact factor: 5.191

4.  Empiric therapy for cancer patients: comparative study of ticarcillin-tobramycin, ticarcillin-cephalothin, and cephalothin-tobramycin.

Authors:  J Klastersky; C Hensgens; L Debusscher
Journal:  Antimicrob Agents Chemother       Date:  1975-05       Impact factor: 5.191

5.  Comparative in vitro activities of azlocillin-cefotaxime and azlocillin-tobramycin combinations against blood and multi-drug resistant bacterial isolates.

Authors:  R J Fass
Journal:  Antimicrob Agents Chemother       Date:  1982-07       Impact factor: 5.191

6.  Bacteriostatic and bactericidal activities of beta-lactam antibiotics enhanced by the addition of low concentrations of gentamicin.

Authors:  G Masuda; K Nakamura; T Yajima; K Saku
Journal:  Antimicrob Agents Chemother       Date:  1980-03       Impact factor: 5.191

7.  The use of tombramycin in the management of severe infections. Clinical and pharmacological data.

Authors:  D Baron; H Drugeon; F Nicolas; A Courtieu
Journal:  Eur J Intensive Care Med       Date:  1976-09

8.  Activity of newer aminoglycosides and carbenicillin, alone and in combination, against gentamicin-resistant Pseudomonas aeruginosa.

Authors:  M I Marks; S Hammerberg; G Greenstone; B Silver
Journal:  Antimicrob Agents Chemother       Date:  1976-09       Impact factor: 5.191

9.  Susceptibility of Pseudomonas aeruginosa to tobramycin or gentamicin alone and combined with carbenicillin.

Authors:  E L Anderson; P K Gramling; P R Vestal; W E Farrar
Journal:  Antimicrob Agents Chemother       Date:  1975-09       Impact factor: 5.191

Review 10.  Tobramycin: a review of its antibacterial and pharmacokinetic properties and therapeutic use.

Authors:  R N Brogden; R M Pinder; P R Sawyer; T M Speight; G S Avery
Journal:  Drugs       Date:  1976       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.